Mutations in the TGFBR2 gene seem to be responsible for inactivation of the TGF-β pathway in colon cancer cells, which is a gene that encodes the TGF-β receptor, leading to abnormal cellular activities in colon cancer [21]. This evidence concerns the gene TGFBR2 and colonic neoplasm.